Impact of the COVID-19 pandemic on participants in pragmatic clinical trials for chronic pain: implications for trial outcomes and beyond
Negative impacts of the pandemic on individuals living with chronic pain cut across aspects of life that are also central to effective pain management, including access to health care, social support, and mental and emotional health, with differential impacts found across key demographic and clinical factors. These findings should yield consideration of pandemic impacts in clinical practice and as moderating effects of treatment outcomes in clinical trials conducted during the pandemic.
Authors
- John Sellinger (ORCID: https://orcid.org/0000-0002-8870-5085)
- Diana J. Burgess (ORCID: https://orcid.org/0000-0003-1139-7739)
- Steve Martino (ORCID: https://orcid.org/0000-0002-7308-6592)
- Kathryn Gilstad‐Hayden
- Diana M. Higgins (ORCID: https://orcid.org/0000-0002-6885-266X)
- Christina M. Lazar (ORCID: https://orcid.org/0000-0003-1732-1516)
- Natalie Purcell (ORCID: https://orcid.org/0000-0002-0582-9235)
- Karen H. Seal (ORCID: https://orcid.org/0000-0002-6676-9117)
- Marc I. Rosen
- Alicia A. Heapy (ORCID: https://orcid.org/0000-0003-1284-8263)
Institutions
- Boston University (US)
- University of Minnesota (US)
- University of California, San Francisco (US)
- Yale University (US)
- VA Connecticut Healthcare System (US)
- Minneapolis VA Health Care System (US)
- Durham VA Health Care System (US)
- University of Minnesota Medical Center (US)
- San Francisco VA Health Care System (US)
- University of San Francisco (US)
Publication Details
- Journal
- Pain Medicine
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1093/pm/pnae060
- Citations
- 3
- Primary Topic
- Musculoskeletal pain and rehabilitation
- Type
- article
- Field-Weighted Citation Impact
- 1.34
Funders
- U.S. Department of Defense
- U.S. Department of Veterans Affairs
- National Institutes of Health